This issue was suggested to be solved by using REQORSA as Fus1/Tusc2-based genetic therapy in mouse model of lung cancer reduced expression of array of IC molecules (TIM-3, CTLA-4, PD-1) concomitant with anti-tumor response [20]. This evidence concerns the gene CTLA4 and neoplasm.